Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.


The peripheral leukocyte migration inhibition test has been used to assess cellular immunity to soluble antigen extracts of breast cancer in patients and normal controls. In sequential tests over several weeks, 23 of 23 patients with breast cancer in remission reacted intermittently, with 67 of 139 tests (48%) being positive (greater than or equal to 20… (More)


1 Figure or Table

Slides referencing similar topics